Answers are grounded in this paper and cite their sources.
This research demonstrates human insulin expression in planta using a ZYMV viral vector, highlighting enhanced targeting mechanisms.
A plant viral vector engineered from an in vivo infectious clone of zucchini yellow mosaic virus (Potyvirus cucurbitaflavitesselati; ZYMV) was used to express the human insulin in planta. The proinsulin gene was in frame inserted between the P1 and HC-Pro genes of the ZYMV vector. Six histidine residues and a NIa protease cleavage site were added at the C-terminal region of the inserts to facilitate detection and process of free form of the ex-pressed insulin, respectively. Also, N-terminal chloroplast signal peptide and C-terminal KDEL sequence was used to target insulin into chloroplast and endoplasmic reticulum, respectively. The infectious activity of the recombinant vectors was approved by rubbing the plasmid on Chenopodium quinoa and observing local lesions. A single local lesion was inoculated on zucchini squash leaves and these plants were sampled 5, 10, 15 and 20 days after inoculation. Analysis of inoculated plants by enzyme-linked immunosorbent assay (ELISA) and western blot indicated that insulin protein was expressed in Squash leaves. RT-PCR result showed the recombinant vector was remarkably stable in squash for seven serial passages and after 30 days. Also, using KDEL retention signal increased ex-pression level of recombinant protein significantly. This procedure provides a convenient and fast way for production of large quantities of insulin in planta.
No takes yet. Share an insight, caveat, or question.
Hosseini et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: